Chemoinformaics analysis of 2-O-METHYLPENTOFURANOSE
| Molecular Weight | 164.157 | nRot | 2 |
| Heavy Atom Molecular Weight | 152.061 | nRig | 5 |
| Exact Molecular Weight | 164.068 | nRing | 1 |
| Solubility: LogS | 0.227 | nHRing | 1 |
| Solubility: LogP | -1.903 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 22.0315 |
| nHD | 3 | BPOL | 15.5105 |
| QED | 0.443 |
| Synth | 3.621 |
| Natural Product Likeliness | 3.008 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.027 |
| HIA | 0.707 |
| CACO-2 | -5.197 |
| MDCK | 0.00098007 |
| BBB | 0.385 |
| PPB | 0.102683 |
| VDSS | 0.681 |
| FU | 0.853715 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.104 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.635 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.076 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.192 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.054 |
| CL | 2.05 |
| T12 | 0.692 |
| hERG | 0.03 |
| Ames | 0.423 |
| ROA | 0.205 |
| SkinSen | 0.112 |
| Carcinogencity | 0.026 |
| EI | 0.073 |
| Respiratory | 0.025 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.925241 |